Treat as representation PIL for obtaining plasma from recovered COVID-19 patients: Delhi HC

By: |
Published: July 3, 2020 1:19 PM

The petition had claimed that the Centre and Delhi government were not taking effective steps for ensuring sufficient availability plasma for treatment of COVID-19 patients.

The bench was of the view that people cannot be forced to donate plasma.The bench was of the view that people cannot be forced to donate plasma.

The Delhi High Court on Friday declined to entertain a PIL seeking directions to the Centre and the AAP government to make it mandatory to obtain plasma from patients who recovered from COVID-19 either at home or at a hospital and directed that it be treated as a representation.

A bench of Chief Justice D N Patel and Justice Prateek Jalan said people cannot be forced to give an undertaking to donate plasma before receiving treatment for COVID-19 and it has to be voluntary.

The court asked the respondents — Centre, Delhi government, National Disaster Management Authority and various civic bodies — to treat as a representation the Public Interest Litigation (PIL) which had sought framing of guidelines and constitution of a statutory body to regulate the smooth availability of plasma.

The petition had claimed that the Centre and Delhi government were not taking effective steps for ensuring sufficient availability plasma for treatment of COVID-19 patients.

The plea had also sought to make it obligatory on the part of every recovered patient to donate plasma at first instance.

However, the bench was of the view that people cannot be forced to donate plasma.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Glenmark to launch higher strength of FabiFlu for treatment of mild to moderate Covid
2Covid-19: Maharashtra records highest single-day spike of 11,514 cases, 316 deaths
3Covid-19: Israel claims ‘excellent vaccine in hand’; set to start human trials